• Financial Planning

    In finance, investment is putting money into an asset with the expectation of capital appreciation.

  • Mutual Funds

    When it comes to the world of investing, three words come to mind: overwhelming, intimidating, and scary.

  • Time for changes

    Bottoms in the investment world don't end with four-year lows; they end with 10- or 15-year lows.

Financial Calculator
  • SIP Calculator
  • EMI Calculator
  • Lumpsum Calculator
  • Child Education Calculator
  • Child Marriage Planning
  • Retirement Calculator
  • SIP Past Performance
  • STP Past Performance
  • SWP Past performance
  • Lumpsum Planning
  • Dividend History
  • NAV Viewer
  • Income Tax Calculator
  • Human Life Calculator
  • Delay Cost Calculator
  • SIP-O-METER

SIP Calculator

EMI Calculator

Lumpsum Calculatore

Child Education Calculator

Child Marriage Planning

Retirement Planning Calculator

SIP Past Performance

STP Past Performance

SWP Past performance

Lumpsum Planning

Dividend History

NAV Viewer

Income Tax Calculator

Human Life Calculator

Delay Cost Calculator

SIP-O-METER


Regular investing in MF schemes reached a new milestone, with SIP accounts crossing 4 crore and SIP AUM reaching an all-time high of Rs 483,964 crore
Fri, 09 Jul 2021 12:12:17 +0530


The stock closed at Rs 125.85 on BSE, up 65.59 percent with respect to the issue price, while on NSE, the stock closed at Rs 125.30, up 64.87 percent against the stock#39;s issue price of Rs 76.
Fri, 23 Jul 2021 10:00:26 +0530


Glenmark Life Sciences IPO: The company plans to raise Rs 1,497.85 crore at the lower end and Rs 1,513.6 crore at the higher end of the price band.
Thu, 22 Jul 2021 09:35:46 +0530


Glenmark Life IPO: The IPO comprises a fresh issue of Rs 1,060 crore and an offer for sale of 63 lakh equity shares by promoter Glenmark Pharmaceuticals
Wed, 21 Jul 2021 08:21:28 +0530


Tatva Chintan IPO: The company shares traded at a premium of Rs 700-750 in the grey market at time of writing this copy
Tue, 20 Jul 2021 11:46:16 +0530


The Rs 963-crore public issue of the road engineering, procurement and construction company was subscribed 102.58 times
Mon, 19 Jul 2021 18:02:00 +0530


Siddhartha Khemka of Motilal Oswal expects Clean Science to do well post listing, given the huge response to the IPO, robust financials and a growing demand for companies in green chemicals
Mon, 19 Jul 2021 17:32:00 +0530


Despite the better-than-expected listing gains, experts advise remaining invested in the stock for the long-term given the company#39;s strong financials and fundamentals, international presence, and leading position in several critical products.
Mon, 19 Jul 2021 16:19:45 +0530


Given the stellar debut, experts advise short-term investors to book profits. However, long-term investors can hold the stock. New investors, or existing investors looking to add to their position, should wait for a more opportune time, they say.
Mon, 19 Jul 2021 15:14:43 +0530


The specialty chemical company opened its IPO for subscription on July 16. It was subscribed 4.5 times on the first day of bidding.
Mon, 19 Jul 2021 11:38:20 +0530


Clean Science IPO: The company manufactures functionally critical specialty chemicals such as performance chemicals, pharmaceutical intermediates, and FMCG chemicals.
Mon, 19 Jul 2021 10:00:42 +0530


GR Infra IPO: The company is well placed to meet its funds requirement for growth with low debt and ready monetizable assets, said Yes Securities.
Mon, 19 Jul 2021 10:00:38 +0530


Strong financials, growth potential, dominant position and potential play on green chemistry has helped Tatva Chintan IPO garner huge interest
Sat, 17 Jul 2021 09:59:08 +0530


The specialty chemical company is planning to raise Rs 500 crore through public issue which comprises a fresh issue of Rs 225 crore and an offer for sale of Rs 275 crore by promoter and promoter group.
Fri, 16 Jul 2021 15:04:52 +0530


Hem Securities has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 15, 2021.
Fri, 16 Jul 2021 14:33:51 +0530


Motilal Oswal has come out with its report on Tatva Chintan Pharma Chem. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on July 15, 2021.
Fri, 16 Jul 2021 14:14:57 +0530